Integrated genomic and transcriptomic analysis to predict FOLFIRINOX response in metastatic pancreatic ductal adenocarcinoma

被引：0
|
作者：
Lansbergen, Marjolein Francisca
Dings, Mark Pui Gien
Koster, Jan
Wilmink, Johanna
Van Laarhoven, Hanneke W. M.
Bijlsma, Maarten F.
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Amsterdam UMC, Ctr Expt Mol Med, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4153
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Identification of Carboxylesterase-2 as a determinant of response to irinotecan and neoadjuvant FOLFIRINOX therapy in pancreatic ductal adenocarcinoma
    Capello, Michela
    Lee, Minhee
    Wang, Hong
    Babel, Ingrid
    Katz, Matthew H.
    Fleming, Jason B.
    Maitra, Anirban
    Wang, Huamin
    Tian, Weihua
    Taguchi, Ayumu
    Hanashi, Samir M.
    CANCER RESEARCH, 2015, 75
  • [42] Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma
    Ecker, Brett L.
    Court, Colin M.
    Janssen, Quisette P.
    Tao, Alice J.
    D'Angelica, Michael, I
    Drebin, Jeffrey A.
    Gonen, Mithat
    O'Reilly, Eileen M.
    Jarnagin, William R.
    Wei, Alice C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (02) : 342 - 349
  • [43] Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma
    Meijer, Laura L.
    Frampton, Adam E.
    Garajova, Ingrid
    Caparello, Chiara
    Le Large, Tessa Y. S.
    Funel, Niccola
    Vasile, Enrico
    Stebbing, Justin
    Krell, Jonathan
    Kazemier, Geert
    Giovannetti, Elisa
    LANCET, 2017, 389 : 68 - 68
  • [44] SURGICAL MANAGEMENT OF METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
    Hyman, David
    Almerey, Tariq
    Hammons, Isaac
    Mujkanovic, Amer
    Betros, Trevor
    Stauffer, John
    GASTROENTEROLOGY, 2022, 162 (07) : S1360 - S1360
  • [45] Role of ALCAM in Metastatic Pancreatic Ductal Adenocarcinoma
    Jacob, H. Charles
    Richard, J. Charles
    Lavania, S.
    Signorelli, R.
    Gomez, B. A.
    Giret, T. M.
    Saluja, A. K.
    PANCREAS, 2021, 50 (07) : 1050 - 1051
  • [46] FOLFIRINOX chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma: A retrospective analysis of toxicity and outcomes
    Kerr, Ashleigh
    Grose, Derek B.
    Hall, Sally
    McIntosh, David
    MacLaren, Vivienne
    Ali, Clinton
    Hennessy, Aisling
    McDonald, Alexander
    Graham, Janet Shirley
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [47] Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRI
    Nikolaou, Christos
    Matikas, Alexios
    Papavasilopoulou, Maria
    Mavroudis, Dimitris
    Vamvakas, Lampros
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [48] A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma
    Yin, Chao
    Marshall, John
    Macke, Laura Ann
    He, Aiwu Ruth
    Bouker, Kerrie
    Weinberg, Benjamin Adam
    Mukherji, Reetu
    Weiner, Louis M.
    Wang, Hongkun
    Geng, Xue
    Hoke, Frank
    Youssoufian, Hagop
    El-Hariry, Iman
    Noel, Marcus Smith
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] A pilot, non-randomized evaluation of the safety of anakinra plus FOLFIRINOX in metastatic pancreatic ductal adenocarcinoma patients.
    Whiteley, Andrew
    Becerra, Carlos
    McCollum, David
    Paulson, Andrew Scott
    Goel, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] MECHANISTIC EXAMINATION OF THE FOLFIRINOX CHEMOTHERAPEUTIC DRUG REGIMEN ON PANCREATIC DUCTAL ADENOCARCINOMA CELLS
    Byrne, E.
    Chaudhuri, Roy T.
    Lin, Q.
    Vaidya, T.
    Trueman, S.
    Straubinger, N.
    Straubinger, R.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S21 - S21
12345